QUANTUM X LABS INC. quarterly report, Q2 FY2018

Business context and reporting period

The filing is Virtual Crypto Technologies, Inc.’s unaudited Form 10-Q for the quarter and six months ended June 30, 2018, signed August 14, 2018. The request identifies Quantum X Labs Inc., but that is not the registrant named in this filing.

The company shifted from skin-imaging technology to developing and marketing cryptocurrency transaction software and hardware under the NetoBit brand. It ceased its former DermaCompare operations in January 2018; its former subsidiary, Emerald Israel, was ordered wound up in May 2018.

Financial results and position

MetricThree months ended June 30, 2018Six months ended June 30, 2018
Revenue$0$0
Operating expenses$623,469$2,051,763
Net loss from continuing operations$3,239,229$24,041,605
Basic and diluted loss per share$0.05 total$0.46 total
Cash used in continuing operating activities $935,193 for the six months

Six-month net loss included $21,989,842 of net finance expense, primarily related to changes in convertible-note terms. The filing reports no revenue, so a revenue margin is not meaningful. There was no investing cash flow in the first half. Financing provided $2,041,013, including $1,940,950 from stock and warrant sales and $100,000 from convertible notes; cash rose to $1,108,779.

At June 30, 2018, current assets were $1,167,102, including $1,108,779 cash and $58,323 in short-term investments. Current liabilities were $1,195,400, leaving negative working capital of $28,298. Total liabilities were $1,195,400; the balance sheet showed $438,264 of short-term convertible notes after discounts. Note principal was $982,611, with a $544,347 discount. Stockholders’ deficit was $28,298.

Material changes versus prior comparable periods

  • Revenue remained zero. First-half operating expenses rose to $2,051,763 from $553,026 in 2017, including $630,965 in research and development for the new crypto products and higher general and administrative costs, partly reflecting share-based consultant compensation.
  • First-half net loss increased from $1,694,608 in 2017 to $24,041,605 in 2018, principally because the 2018 period included a $21,472,897 finance loss from the convertible-note modification, as well as debt-discount amortization.
  • Cash increased from $2,959 at December 31, 2017 to $1,108,779 at June 30, 2018, primarily following the first-half equity financing. Common shares outstanding rose from 22,543,008 to 63,726,591.

Outlook, risks, contingencies and unusual items

  • Management said available funds should support its business plan through June 2019 and that it had no current plan to seek more capital. However, the filing also states that additional financing is necessary, no external funding is committed, and substantial doubt exists about the company’s ability to continue as a going concern.
  • A Chiron distributor arrangement contemplated a $250,000 appointment fee, of which $100,000 had been received by June 30 ($50,000 cash and $50,000 in Chiron shares). The filing also describes a potential Nigeria distribution option. These arrangements are not reported as product revenue; the $100,000 was recorded as deferred revenue.
  • Management described NetoBit as enabling real-time confirmation of cryptocurrency transactions and faster execution, but the filing reports no revenue from the products and provides no quantified commercialization forecast or formal financial guidance.
  • Emerald Israel’s winding-up process may yield no excess proceeds for the company, according to management’s estimate. Liabilities held for sale were $482,822. Former employees’ claims of less than $96,000 are included in current liabilities. A former executive’s lawsuit seeks $100,000; the company disputes the claim and says it does not expect a material effect.
  • Disclosure controls and procedures were ineffective at quarter-end because of material weaknesses, which management attributed to inadequate resources and personnel.
  • The convertible-note amendment produced an unusually large noncash finance charge and substantial equity accounting entries. The filing reports $1,044,144 of shares and warrants issued for services during the first half.

Important facts for investors to verify

  1. Confirm the issuer’s identity: this filing names Virtual Crypto Technologies, Inc., not Quantum X Labs Inc.
  2. Review the full convertible-note terms, the accounting for the modification and beneficial conversion features, and the timing and amount of any remaining repayment obligations.
  3. Assess whether the company can commercialize NetoBit, meet distributor conditions, generate revenue, and fund operations beyond the stated June 2019 runway.
  4. Check potential dilution from the increase in shares outstanding and the large outstanding warrant issuances, and review the terms and expiry dates of those securities.
  5. Monitor Emerald Israel’s liquidation, associated liabilities and claims, and any resolution of the reported lawsuits.
  6. Review remediation of the disclosed material weaknesses and the company’s subsequent liquidity and financing disclosures.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.